Published September 6, 2024
Cellevate appoints bioprocessing industry expert Bettina Berendsen as Board Observer and Strategic Advisor
LUND, Sweden – Cellevate AB, an innovative biotech company developing the next generation of cell culture systems based on nanotechnology, is pleased to announce the appointment of Bettina Berendsen as Board of Directors Observer as well as Strategic Advisor. Bettina Berendsen is an executive leader with over 35 years of extensive experience in the global…
Published June 5, 2024
Cellevate appoints bioprocessing expert Dr. Christel Fenge as Strategic Advisor
LUND, Sweden – Cellevate AB, an innovative biotech company developing the next generation of cell culture systems designed to revolutionize biomanufacturing, is pleased to announce the appointment of Dr. Christel Fenge as Strategic Advisor. Dr. Fenge brings over 30 years of experience in various leadership roles across the bioprocessing and biopharmaceutical industry. Dr. Fenge previously…
Published March 15, 2024
Cellevate announces poster presentation at Advanced Therapies in London, UK, on March 19-20, 2024
LUND, Sweden – Cellevate AB, an innovative biotech company developing the next generation of cell culture systems designed to revolutionize biomanufacturing, today announces a poster presentation at the Advanced Therapies congress in London on March 19-20, 2024. In the poster, we present positive results on the use of the 1st nanofiber-based microcarriers, Cellevat3dTM microcarriers, in…
Published March 14, 2024
Cellevate announces the appointment of renowned industrial biotechnology and bioprocessing expert Dr. Uwe Gottschalk as new Chairman of the Board of Directors
LUND, Sweden – Cellevate AB, an innovative biotech company developing the next generation of cell culture systems designed to revolutionize biomanufacturing, announces that Dr. Uwe Gottschalk has been elected as Chairman to its Board of Directors. The appointment follows the resignation of Mats Leifland, who served as Chairman of the Board until March 12, 2024….
Published March 14, 2024
Cellevate tillkännager utnämningen av Dr. Uwe Gottschalk, välkänd expert inom industriell bioteknik och bioprocesser, till ny styrelseordförande
LUND, Sverige – Cellevate AB, ett innovativt bioteknikföretag som utvecklar nästa generations cellodlingssystem designat för att revolutionera bioproduktion, meddelar att Dr. Uwe Gottschalk har valts till styrelseordförande. Dr. Gottschalk efterträder därmed Mats Leifland, som var styrelseordförande fram till den 12 mars 2024. Dr. Gottschalk bidrar med omfattande erfarenheter inom bioteknikområdet och har en framstående karriär…
Published December 18, 2023
Inauguration of Cellevate’s new upstream bioprocessing cell culture laboratory at Medicon Village in Lund
LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, celebrated last week the inauguration of its new, larger premises at Medicon Village in Lund, Sweden. The highlight of the event was the official opening of the internal upstream bioprocessing cell culture facility,…
Published December 4, 2023
Cellevate progresses to second half of the European Innovation Council Accelerator project focused on scaling up for the commercialization of Cellevat3d™ microcarriers in bioprocessing applications
LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, has successfully received the European Innovation Council (EIC) Accelerator project half time progress approval. The project which started in October 2022, is dedicated to develop and scale up the company for the large-scale…
Published October 10, 2023
Cellevate raises 39 million SEK in Seed Financing to accelerate their global commercial launch
LUND, Sweden – Cellevate, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, announced today the successful closure of its recent investment round, securing a total of 39 million SEK. The round was led by Industrifonden, in syndication with the European Innovation Council Fund (EIC Fund) and…
Published October 10, 2023
Cellevate tar in 39 miljoner kronor i såddfinansiering för att accelerera global kommersiell lansering
LUND, Sverige – Cellevate, ett innovativt bioteknikföretag som utvecklar nästa generations cellodlingssystem som är utformat för att revolutionera dagens bioproduktion, meddelade idag att företaget framgångsrikt har avslutat sin senaste investeringsrunda och därmed säkrat totalt 39 miljoner kronor. Rundan leddes av Industrifonden, i samarbete med European Innovation Council Fund (EIC Fund) och Onsight Ventures. Cellevates egenutvecklade…
Published October 9, 2023
Cellevate to present at LSX Nordics Congress in Copenhagen on October 11, 2023
LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, today announced that Laura Chirica, CEO, will present at the LSX Nordics Congress in Copenhagen, Denmark. Event details – Cellevate presentation:Day: Wednesday, October 11, 2023Time: Presentation at 11:30 am (CET) For more information, please…
